RL 13 (Erlotinib 150 mg)

Pill with imprint RL 13 is White, Round and has been identified as Erlotinib 150 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RL 13

Erlotinib

Imprint

RL 13

Strength

150 mg

Color

White

Shape

Round

Availability

Prescription only

Drug Class

EGFR inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sun Pharmaceutical Industries Inc.

National Drug Code (NDC)

63304-0135

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "RL 13"

Tizanidine Hydrochloride

Sertraline Hydrochloride

Tamsulosin Hydrochloride

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer